Every material Form 8-K Donaldson filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Donaldson reported first quarter fiscal 2026 results for the quarter ended October 31, 2025, with sales up 3.9% to $935.4 million and GAAP net earnings of $113.9 million, up 15.1% from a year earlier. The company raised its fiscal 2026 adjusted EPS and adjusted operating margin guidance, which points to improved earnings expectations for shareholders.
Net sales were $935.4 million, up 3.9%, with Mobile Solutions up 4.5% and On-Road down 27.1%.
GAAP diluted EPS was $0.97 versus $0.81; adjusted diluted EPS was $0.94, up 13.3%.
Fiscal 2026 adjusted EPS guidance was raised to $3.95 to $4.11 from $3.92 to $4.08.
Operating margin was 16.0% versus 14.5%; adjusted operating margin was 15.5%, and fiscal 2026 adjusted operating margin guidance rose to 16.2% to 16.8%.
Donaldson reported fiscal fourth-quarter 2025 sales of $980.7 million, up 4.8%, and GAAP EPS of $0.97, up 7.8%. For the full year, sales rose 2.9% to $3.7 billion, but GAAP EPS fell 9.8% to $3.05, and the company recorded a $62.0 million impairment charge. The company forecast fiscal 2026 EPS of $3.92 to $4.08 and sales growth of 1% to 5%.
Q4 sales $980.7 million, up 4.8%; GAAP EPS $0.97, up 7.8%; adjusted EPS $1.03, up 9.6%
Full-year sales $3.7 billion, up 2.9%; GAAP EPS $3.05, down 9.8%; adjusted EPS $3.68, up 7.6%
Fiscal 2026 EPS forecast $3.92 to $4.08; sales projected to rise 1% to 5%, or $3.8 billion at the midpoint
About $465 million returned to shareholders in fiscal 2025 through share repurchases and dividends
Donaldson Company entered a Second Amendment to its Credit Agreement on June 12, 2025, extending the revolving credit facility's maturity to June 12, 2030 and raising its revolving credit limit to $600 million. A new $200 million term loan was fully advanced on the closing date and matures June 12, 2028. The filing describes the financing terms without reporting any change in operating results.
Revolving credit limit raised from $500 million to $600 million; maturity extended from May 21, 2026 to June 12, 2030.
New $200 million term loan facility, maturing June 12, 2028, was fully advanced at closing.
As of June 12, 2025, about $60 million was outstanding under the revolver and $200 million under the term loan.
Incremental credit facility option increased from $250 million to $350 million.
Donaldson reported fiscal third-quarter 2025 results for the quarter ended April 30, 2025, with net sales up 1.3% to $940.1 million and GAAP net earnings down 49.1% to $57.8 million after a $62.0 million impairment of intangible assets. Adjusted diluted EPS rose 7.6% to $0.99, and the company narrowed its fiscal 2025 adjusted EPS guidance to $3.64 to $3.70, with the midpoint $0.03 above prior guidance. The company also named Richard B. Lewis as chief operating officer, effective August 1, 2025.
Net sales were $940.1 million, up 1.3%; GAAP diluted EPS was $0.48 versus $0.92 a year earlier.
The $62.0 million impairment includes $46.6 million for Univercells Technologies and $15.4 million for Solaris.
Adjusted diluted EPS was $0.99, up 7.6%; fiscal 2025 adjusted EPS guidance is $3.64 to $3.70.
Richard B. Lewis, currently president of Life Sciences, becomes COO on August 1, 2025, with fiscal 2026 base salary set at $750,000.
Thomas R. Scalf, President, Enterprise Operations and Supply Chain, notified Donaldson of his decision to retire effective at the close of business on August 1, 2025. He will provide consulting services through December 31, 2025, to support a transition of his responsibilities, and the filing says the arrangement is intended to facilitate a smooth handover.
Thomas R. Scalf, President, Enterprise Operations and Supply Chain, to retire effective August 1, 2025
Consulting Agreement dated May 14, 2025, runs through December 31, 2025
Scalf will receive $40,000 per month for the five-month consulting period
Donaldson reported fiscal second quarter 2025 results for the quarter ended January 31, 2025, with net sales of $870.0 million, down 0.8% from a year earlier, and GAAP diluted EPS of $0.79 versus $0.81. Adjusted diluted EPS rose to $0.83 from $0.81, and the company narrowed its fiscal 2025 adjusted EPS guidance to $3.60 to $3.68 while raising its adjusted operating margin outlook to 15.6% to 16.0%, so shareholders see mixed headline results with improved adjusted profitability.
Net sales were $870.0 million, down 0.8% year over year and up 0.9% in constant currency; Aftermarket sales rose 4.0% while On-Road sales fell 24.4%.
GAAP diluted EPS was $0.79 versus $0.81 a year ago; adjusted diluted EPS was $0.83, excluding $2.2 million of restructuring charges and $4.4 million of business development charges.
Fiscal 2025 adjusted EPS guidance was narrowed to $3.60 to $3.68, with the midpoint consistent with prior guidance.
Adjusted operating margin guidance was raised to 15.6% to 16.0%, up from 15.3% to 15.9%.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Donaldson filing is on SEC EDGAR ↗. 8-K briefs of other companies →